Recruiting

CPR Video

Sponsor:

Massachusetts General Hospital

Code:

NCT01653938

Conditions

Congestive Heart Failure

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

video decision aid

Study Details

Brief summary:

This is a randomized controlled trial of a CPR video decision aid in patients with advanced congestive heart failure (CHF).

Conditions

Congestive Heart Failure

Study ID

NCT01653938

Start date

Apr, 2011

Status verified date

Nov, 2020

Primary completion date

Sep, 2012

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. A diagnosis of advanced heart failure:

  • New York Heart Association Class III or IV (III: marked limitation in activity due to symptoms, even during less-than-ordinary activity; IV: severe limitations, experiences symptoms while at rest). AND
  • Two or more hospitalizations for heart failure in the last year. AND
  • Either a systolic blood pressure ≤ 120 mm Hg OR Na ≤ 135 mEq/L.
2. Ability to provide informed consent.
3. Ability to communicate in English.
4. Age 65 or older.

Study Design

Enrollment

50 participants

Anticipated

Allocation

Randomized

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

no intervention: control group

experimental: Video Arm

Use of video decision aid in the experimental arm.

Interventions

video decision aid

Primary outcome measure

  • preferences [ Time Frame: 5 minutes after survey ]

Central Contacts and Locations

Locations

Massachusetts General Hospital

Recruiting

Boston, Massachusetts, United States, 02114

Contacts

Angelo Volandes

617-643-4266avolandes@partners.org

Principal Investigator:

Angelo Volandes

More Information

Sponsor

Massachusetts General Hospital

Last update posted

Nov 18, 2020

Last verified

Nov, 2020

Keywords

  • CHF

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2020-11-18.